Targeted Metabolomic Analysis of Serum Fatty Acids for the Prediction of Autoimmune Diseases
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Autoimmune diseases (ADs) are rapidly increasing worldwide and accumulating data support a key role of disrupted metabolism in ADs. This study aimed to identify an improved combination of Total Fatty Acids (TFAs) biomarkers as a predictive factor for the presence of autoimmune diseases. A retrospective nested case-control study was conducted in 403 individuals. In the case group, 240 patients diagnosed with rheumatoid arthritis, thyroid disease, multiple sclerosis, vitiligo, psoriasis, inflammatory bowel disease and other AD were included and compared to 163 healthy individuals. Targeted metabolomic analysis of serum TFAs was performed using GC-MS, and 28 variables were used as input for the predictive models. The primary analysis identified 12 variables that were statistically significantly different between the two groups, and metabolite-metabolite correlation analysis revealed 653 significant correlation coefficients with 90% level of significance (p<0.05). Three predictive models were developed, namely a) a logistic regression based on Principal Component Analysis (PCA), b) a straightforward logistic regression model and c) an Artificial Neural Network (ANN) model. PCA and straightforward logistic regression analysis, indicated reasonably well adequacy (74.7% and 78.9% respectively). For the ANN, a model using two hidden layers and 11 variables was developed, resulting in 76.2% total predictive accuracy. The models identified important biomarkers: lauric acid (C12:0), myristic acid (C14:0), stearic acid (C18:0), lignoceric acid (C24:0), palmitic acid (C16:0) and heptadecanoic acid (C17:0) among saturated fatty acids, Cis-10-pentadecanoic acid (C15:1), Cis-11-eicosenoic acid (C20:1n9) and erucic acid (C22:1n9) among monounsaturated fatty acids and the Gamma-linolenic acid (C18:3n6) polyunsaturated fatty acid. The metabolic pathways of the candidate biomarkers are discussed in relation to ADs. The findings indicate that the metabolic profile of serum TFAs is associated with the presence of ADs and can be an adjunct tool for the early diagnosis of ADs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principal component analysis: A review and recent developments
Jolliffe, I. T., & Cadima, J. (2016) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2015.0202 · Cited by 10,117
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Logistic regression and Artificial Neural Network Classification models: A methodology review
Dreiseitl, S., & Ohno-Machado, L. (2002) · Journal of Biomedical Informatics · doi:10.1016/s1532-0464(03)00034-0 · Cited by 2,177
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045 · cited 1×
“Total fatty acids (TFAs) are valuable markers of inflammation and gain increasing attention in cases of chronic inflammation as in ADs (Serhan et al., 2007).”
BackgroundDesigning Health Care for the Most Common Chronic Condition—Multimorbidity
Tinetti, M. E., Fried, T. R., & Boyd, C. M. (2012) · JAMA · doi:10.1001/jama.2012.5265 · Cited by 1,005
The multiple pathways to autoimmunity
Theofilopoulos, A. N., Kono, D. H., & Baccala, R. (2017) · Nature Immunology · doi:10.1038/ni.3731 · Cited by 590
Ernster, V. L. (1994) · Preventive Medicine · doi:10.1006/pmed.1994.1093 · Cited by 299 · cited 2×
“A retrospective nested case-control study (Ernster, 1994) was conducted based on 5.850 subjects who visited the “Health clinic for autoimmune and chronic diseases” in Athens, Greece during the period of 3/8/2012 till 29/12/2017.”
MethodInfluentialWhy Match? Investigating Matched Case-Control Study Designs with Causal Effect Estimation
Rose, S., & van der Laan, M. J. (2009) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1127 · Cited by 293
Carlé, A., Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., Rasmussen, L. B., Jørgensen, T., & Laurberg, P. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0356 · Cited by 107
Yakoob, M. Y., Shi, P., Hu, F. B., Campos, H., Rexrode, K. M., Orav, E. J., Willett, W. C., & Mozaffarian, D. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.083097 · Cited by 92
Cited by
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
Self-citationSharifi-Rad, J., Quispe, C., Imran, M., Rauf, A., Nadeem, M., Gondal, T. A., Ahmad, B., Atif, M., Mubarak, M. S., Sytar, O., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3268136 · Cited by 389
“Healthy cells produce telomerase in small amounts or not at all, so telomeres are progressively shortened until they reach a critical length, which triggers cell death or replicative senescence [66].”
BackgroundSelf-citationObesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review)
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., Kouretas, D., Spandidos, D., & Tsatsakis, A. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11127 · Cited by 388
Self-citationRahaman, M. M., Hossain, R., Herrera‐Bravo, J., Islam, M. T., Atolani, O., Adeyemi, O. S., Owolodun, O. A., Kambizi, L., Daştan, S. D., Calina, D., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3217 · Cited by 374
Self-citationDiosgenin: An Updated Pharmacological Review and Therapeutic Perspectives
Semwal, P., Painuli, S., Abu-Izneid, T., Rauf, A., Sharma, A., Daştan, S. D., Kumar, M., Alshehri, M. M., Taheri, Y., Das, R., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1035441 · Cited by 195
“or it can be caused by a variety of factors that a ff ect the liver, such as viruses or alcohol consumption [142 – 144].”
Reversal of brain aging by targeting telomerase: A nutraceutical approach
Tsoukalas, D., Buga, A., Docea, A., Sarandi, E., Mitrut, R., Renieri, E., Spandidos, D., Rogoveanu, I., Cercelaru, L., Niculescu, M., et al. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5032 · Cited by 40
“Telomerase is inactive or expressed at low levels in the majority of somatic cells; however, an increased activity is observed in highly prolifer‑ ating cells, such as adult stem cells, male sperm cells, activated lymphocytes and some epidermal cells (7,8).”
Self-citationStruja, T., Wolski, W., Schapbach, R., Mueller, B., Laczko, E., & Schuetz, P. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.07.029 · Cited by 11
Metadata
- Authors
- Tsoukalas, D., Fragoulakis, V., Sarandi, E., Docea, A. O., Papakonstaninou, E., Tsilimidos, G., Anamaterou, C., Fragkiadaki, P., Aschner, M., Tsatsakis, A., Drakoulis, N., & Calina, D.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2019-11-01
- Volume
- 6
- Pages
- 120-120
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W2988238865
- Cited by
- 95
- References
- 10
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.